Great news out of HQ this morning. Incidence of onset of SOM decreased markedly, as well as duration. This is partnership news, and with 3 proven applications for B, and more on the back burner, it won't be much longer for BP to realize the ability this drug has to treat many conditions. Investors here have believed this for quite some time now. don't forget that amidst all the "Brilacidin Buzz", Prurisol toppling lurks. Anyone who hasn't taken a position that is thinking about it, what are you waiting for? Anything under 5 bucks is an EXTREME BARGAIN. Quit procrastinating. You'll be glad you did soon.